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BACKGROUND
Recent trials have questioned the benefit of early parenteral nutrition in adults. The effect 
of early parenteral nutrition on clinical outcomes in critically ill children is unclear.
METHODS
We conducted a multicenter, randomized, controlled trial involving 1440 critically ill 
children to investigate whether withholding parenteral nutrition for 1 week (i.e., provid-
ing late parenteral nutrition) in the pediatric intensive care unit (ICU) is clinically supe-
rior to providing early parenteral nutrition. Fluid loading was similar in the two groups. 
The two primary end points were new infection acquired during the ICU stay and the 
adjusted duration of ICU dependency, as assessed by the number of days in the ICU and 
as time to discharge alive from ICU. For the 723 patients receiving early parenteral nutri-
tion, parenteral nutrition was initiated within 24 hours after ICU admission, whereas for 
the 717 patients receiving late parenteral nutrition, parenteral nutrition was not provided 
until the morning of the 8th day in the ICU. In both groups, enteral nutrition was at-
tempted early and intravenous micronutrients were provided.
RESULTS
Although mortality was similar in the two groups, the percentage of patients with a new 
infection was 10.7% in the group receiving late parenteral nutrition, as compared with 
18.5% in the group receiving early parenteral nutrition (adjusted odds ratio, 0.48; 95% 
confidence interval [CI], 0.35 to 0.66). The mean (±SE) duration of ICU stay was 6.5±0.4 
days in the group receiving late parenteral nutrition, as compared with 9.2±0.8 days in 
the group receiving early parenteral nutrition; there was also a higher likelihood of an 
earlier live discharge from the ICU at any time in the late-parenteral-nutrition group 
(adjusted hazard ratio, 1.23; 95% CI, 1.11 to 1.37). Late parenteral nutrition was associ-
ated with a shorter duration of mechanical ventilatory support than was early parenteral 
nutrition (P = 0.001), as well as a smaller proportion of patients receiving renal-replace-
ment therapy (P = 0.04) and a shorter duration of hospital stay (P = 0.001). Late parenteral 
nutrition was also associated with lower plasma levels of γ-glutamyltransferase and alka-
line phosphatase than was early parenteral nutrition (P = 0.001 and P = 0.04, respectively), 
as well as higher levels of bilirubin (P = 0.004) and C-reactive protein (P = 0.006).
CONCLUSIONS
In critically ill children, withholding parenteral nutrition for 1 week in the ICU was clinically 
superior to providing early parenteral nutrition. (Funded by the Flemish Agency for Innova-
tion through Science and Technology and others; ClinicalTrials.gov number, NCT01536275.)
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Critically ill children cannot normally be fed by mouth, and as a result a pronounced macronutrient deficit often 
develops after a few days. This macronutrient defi-
cit has been associated with infections, weak-
ness, prolonged mechanical ventilation, and de-
layed recovery.1-3 In order to prevent or limit the 
development of this macronutrient deficit, cur-
rent guidelines, which are based largely on small 
studies with surrogate end points and on expert 
opinion, advise care providers to initiate nutri-
tional support soon after a child’s admission to the 
pediatric intensive care unit (ICU).4-6 The pre-
ferred route for the administration of nutritional 
support in the pediatric ICU is the nasogastric 
tube,7 but enteral nutrition is often delayed or 
interrupted.8,9 Since nutrition should equal basic 
metabolic needs and in children should allow 
for growth, children require relatively more mac-
ronutrients than adults. Hence, the current stan-
dard of pediatric intensive care is to meet these 
requirements early.7,10 When enteral nutrition fails, 
parenteral nutrition is advised,5,6 but current nu-
tritional practices in pediatric ICUs vary owing to 
concerns about the overdosing of parenteral nu-
trition.8,11
There is a dearth of adequately powered, ran-
domized, controlled trials that address the effects 
of parenteral nutrition on clinical outcomes in 
critically ill children.12 With respect to critically ill 
adults, recent large, randomized, controlled trials 
have questioned the benefit of early parenteral 
nutrition.13-15 Therefore, in this international, mul-
ticenter, randomized, controlled trial, we investi-
gated whether a strategy of withholding paren-
teral nutrition up to day 8 (late parenteral nutrition) 
in the pediatric ICU is clinically superior to the 
current practice of early parenteral nutrition.
Me thods
Design and Oversight
The Early versus Late Parenteral Nutrition in the 
Pediatric Intensive Care Unit (PEPaNIC) trial was 
a multicenter, prospective, randomized, controlled, 
parallel-group superiority trial.16 The institutional 
review board at each participating site approved 
the protocol (available with the full text of this 
article at NEJM.org).16 The first and last authors 
vouch for the fidelity of the study to the protocol 
and for the accuracy and completeness of the re-
ported data.
From June 18, 2012, through July 27, 2015, all 
children (from term newborns to children 17 years 
of age) who were admitted to one of the partici-
pating pediatric ICUs were eligible for inclusion 
if a stay of 24 hours or more in the ICU was 
expected, if they had a score on the Screening 
Tool for Risk on Nutritional Status and Growth 
(STRONGkids) of 2 or more (with a score of 0 in-
dicating low risk of malnutrition, a score of 1 to 
3 indicating medium risk, and a score of 4 to 5 
indicating high risk),17 and if none of the criteria 
for exclusion were met (see Table S1 in the Sup-
plementary Appendix, available at NEJM.org). 
Written informed consent was requested from 
parents or legal guardians before elective admis-
sion to the pediatric ICU. For emergency admis-
sions, consent was requested within 24 hours 
after the child’s admission to the pediatric ICU.
At each center, consecutive, eligible patients 
were randomly assigned to one of the two treat-
ment groups in a 1:1 ratio. Concealment of group 
assignment was ensured by the use of a central 
computerized randomization system. The ran-
domization was stratified in permuted blocks of 
10 according to age (<1 year or ≥1 year) and diag-
nosis on admission (medical–neurologic, medi-
cal–other, surgical–cardiac, or surgical–other). 
The block size was unknown to the medical and 
research teams. Outcome assessors and investi-
gators who were not directly involved in ICU 
patient care were unaware of the treatment as-
signments.
An independent data and safety monitoring 
board planned to perform two interim analyses 
of the safety end points, one after 480 patients 
had been enrolled and a second after 50% of all 
patients had been enrolled. The board advised that 
recruitment could be continued to completion.
Procedures
All participating centers used early parenteral 
nutrition as the standard of care. Among patients 
assigned to receive early parenteral nutrition, par-
enteral nutrition was initiated within 24 hours af-
ter admission to the pediatric ICU. The dose and 
composition varied according to local guidelines 
(Table S2 in the Supplementary Appendix)16; par-
enteral nutrition was used to supplement any 
enteral nutrition that was provided, with a goal 
toward meeting local macronutrient and caloric 
targets (Table S3 in the Supplementary Appendix). 
Among patients assigned to the late-parenteral-
A Quick Take 
is available at 
NEJM.org
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nutrition group, parenteral nutrition was with-
held up to the morning of day 8 in the pediatric 
ICU. A mixture of intravenous dextrose (5%) and 
saline was administered to the late-parenteral-
nutrition group to match the amount of intrave-
nous fluid administered in the early-parenteral-
nutrition group.16 When blood glucose levels 
spontaneously dropped below 50 mg per deciliter 
(2.8 mmol per liter) in the late-parenteral-nutri-
tion group, the standard 5% dextrose solution 
was replaced with a 10% dextrose solution until 
blood glucose levels exceeded 80 mg per decili-
ter (4.4 mmol per liter) and remained stable.16
In both study groups, enteral nutrition was 
initiated early and was increased in accordance 
with local guidelines. Both study groups also re-
ceived intravenous micronutrients (trace elements, 
minerals, and vitamins) starting from day 2 and 
continuing until the enteral nutrition provided 
reached 80% of the caloric targets. Starting from 
the morning of day 8 in the pediatric ICU, supple-
mentary parenteral nutrition was provided for 
patients in both groups who were not yet receiv-
ing 80% of the caloric target enterally. In Leuven, 
Belgium, an insulin infusion was started in both 
groups to target blood glucose levels of 50 to 
80 mg per deciliter (2.8 to 4.4 mmol per liter) 
in infants (<1 year of age) and 70 mg per deci-
liter (3.9 mmol per liter) to 100 mg per deciliter 
(5.6 mmol per liter) in children (≥1 year of age). 
In Rotterdam, the Netherlands, all patients re-
ceived an insulin infusion designed to target 
blood glucose levels of 72 to 145 mg per deciliter 
(4.0 to 8.0 mmol per liter), with the exception of 
patients with traumatic brain injury, for whom 
the target was 108 mg per deciliter (6.0 mmol 
per liter) to 145 mg per deciliter. In Edmonton, 
Canada, patients received an insulin infusion 
when blood glucose levels exceeded 180 mg per 
deciliter (10.0 mmol per liter). No specific lower 
boundary was set.
Data Collection
All patient data were stored in a logged database 
that was closed 90 days after enrollment of the 
last patient. Because the treatment assignment 
affected the blood glucose level during the first 
24 hours after admission, as expected, the Pedi-
atric Risk of Mortality score could not be used 
to account for the severity of illness at baseline, 
and the Pediatric Logistic Organ Dysfunction 
(PELOD) score (which ranges from 0 to 71, with 
higher scores indicating more severe illness) was 
used instead. The risk of malnutrition at admis-
sion was quantified with use of the STRONGkids 
score.17 The determination of the presence of in-
fection on admission to the pediatric ICU or in-
fection acquired after randomization was based 
on the consensus opinion of two infectious dis-
ease specialists, who made their decision on the 
basis of guidelines in the study protocol (Table 
S4 in the Supplementary Appendix)13; both spe-
cialists were unaware of the study-group assign-
ments. During the time patients were in the ICU, 
daily records were kept regarding all procedures, 
treatments, nutrition provided, and results of 
laboratory analyses. Information on vital status at 
90 days was obtained from national death reg-
istries, hospital information systems, and re-
gional networks of pediatricians and general 
practitioners.
End Points
The two primary end points were new infection 
acquired during the ICU stay and the duration of 
ICU dependency, which was adjusted for five pre-
specified baseline risk factors (diagnostic group, 
age group, severity of illness, risk of malnutri-
tion, and treatment center).16 Among patients with 
a new infection, the duration of antibiotic treat-
ment was compared between the study groups. 
The duration of pediatric ICU dependency was 
quantified as the number of days in the pediatric 
ICU and as the time to discharge alive from the 
pediatric ICU, to account for death as a compet-
ing risk. Discharge from the pediatric ICU was 
defined a priori as the moment when a patient 
was ready for discharge from the pediatric ICU 
(i.e., no longer required or was no longer at risk 
for requiring vital organ support).16 Secondary 
safety end points were death during the first 7 days 
in the pediatric ICU, during the total stay in the 
pediatric ICU, during the stay in the index hos-
pital, and at 90 days after admission to the pediat-
ric ICU and randomization; the number of patients 
with hypoglycemia (glucose level <40 mg per 
deciliter [2.2 mmol per liter]); and the number 
of readmissions to the pediatric ICU within 48 
hours after discharge. Secondary efficacy out-
comes were the time to final (live) weaning from 
mechanical ventilatory support, the duration of 
pharmacologic or mechanical hemodynamic sup-
port, the proportion of patients receiving renal-
replacement therapy, markers of liver dysfunc-
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tion and inflammation, and the time to (live) 
discharge from the hospital.
Statistical Analysis
We calculated that with a sample of 1440 patients 
(approximately 720 patients per group), the study 
would have at least 70% power to detect a 5-per-
centage-point lower rate of new infection in the 
late-parenteral-nutrition group than in the early-
parenteral-nutrition group, assuming an estimat-
ed rate of 20% in the early-parenteral-nutrition 
group, with the use of a two-tailed test at an al-
pha error rate of 5%. All analyses were conducted 
on an intention-to-treat basis.
Variables were summarized as frequencies and 
percentages, medians and interquartile ranges, or 
means and standard errors. Univariable compari-
sons were performed with use of the chi-square 
test (Fisher’s exact test) and the Wilcoxon rank-
sum test. Kaplan–Meier plots were used to illus-
trate time-to-event effects with univariable sig-
nificance that were analyzed by means of log-rank 
testing. The time-to-event effect size was esti-
mated with use of Cox proportional-hazards anal-
ysis, with data censored at 90 days. To take into 
account death as a competing risk for outcomes 
related to duration of care, data for nonsurvivors 
were censored at 91 days (i.e., beyond the date 
for censoring of data for all survivors). These 
time-to-event outcomes were assessed univari-
ably and with adjustment for baseline risk factors 
(diagnostic groups, age group, severity of illness, 
risk of malnutrition, and treatment center). The 
adjusted multivariable analysis of the effect of 
the intervention on dichotomized outcomes was 
performed with the use of logistic regression.
All P values were two-sided, and P values of 
less than 0.05 were considered to indicate statis-
tical significance. No corrections were made for 
multiple comparisons. Because efficacy end points 
were not assessed in the interim analyses, no ad-
justment of the P value threshold for significance 
was required.
To determine whether the effect of the inter-
vention on the primary end points was influenced 
by baseline risk factors, P values for interaction 
were calculated with the use of multivariable lo-
gistic-regression analyses and multivariable Cox 
proportional-hazard analyses with a threshold 
for significance of interaction set at P<0.10. All 
analyses were performed with the use of JMP 
software, version 11.2.0 (SAS Institute).
R esult s
Patients
A total of 1440 patients underwent randomiza-
tion and were included in the analysis (Fig. 1). At 
baseline, the characteristics of the patients were 
similar in the two groups (Table 1). Caloric and 
macronutrient intake per day up to day 16 in the 
pediatric ICU, which illustrates adherence to the 
protocol, is shown in Figure 2, as well as in Fig-
ures S1 and S2 in the Supplementary Appendix.
Primary Outcomes
The rate of acquisition of a new infection was 
7.8 percentage points lower (95% confidence 
interval [CI], 4.2 to 11.4) among children receiv-
ing late parenteral nutrition than among children 
receiving early parenteral nutrition (adjusted odds 
ratio, 0.48; 95% CI, 0.35 to 0.66) (Table 2). This 
result was attributable primarily to the fact that 
fewer patients in the late-parenteral-nutrition 
group acquired an airway or bloodstream infec-
tion (Table 2). Late parenteral nutrition was also 
associated with a shorter stay in the pediatric 
ICU by a mean of 2.7 days (95% CI, 1.3 to 4.3) 
(Table 2), with a higher likelihood of an earlier 
discharge alive from the pediatric ICU at any 
time (adjusted hazard ratio, 1.23; 95% CI, 1.11 
to 1.37) (Table 2 and Fig. 3, and Fig. S3 and 
Table S5 in the Supplementary Appendix).
There were no significant interactions 
(P<0.10) between treatment assignment and any 
of the prespecified risk factors (Table S6 in the 
Supplementary Appendix). However, for the inter-
action between treatment assignment and risk of 
malnutrition, the P value was 0.11, with a lower 
odds of infections with late parenteral nutrition 
than with early parenteral nutrition among chil-
dren at high risk of malnutrition (odds ratio, 
0.28; 95% CI, 0.10 to 0.70) than among those at 
medium risk of malnutrition (odds ratio, 0.54; 
95% CI, 0.38 to 0.76). There was also a higher 
likelihood of an earlier discharge alive from the 
pediatric ICU with late parenteral nutrition among 
the children at high risk of malnutrition (hazard 
ratio, 1.61; 95% CI, 1.12 to 2.31) than among the 
children at medium risk of malnutrition (hazard 
ratio, 1.19; 95% CI, 1.06 to 1.33) (P = 0.19 for the 
interaction).
Similarly, there was no significant interaction 
between treatment assignment and age group. A 
post hoc subgroup analysis of the 209 term neo-
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nates who were less than 4 weeks of age at the 
time of study inclusion revealed that the benefits 
of late parenteral nutrition were similar to or 
greater than those for children 4 weeks of age or 
older (odds ratio for new infections, 0.47 [95% CI, 
0.22 to 0.95] among neonates and 0.48 [95% CI, 
0.33 to 0.69] among older children; P = 0.99 for 
interaction; hazard ratio for the likelihood of 
earlier live discharge from the pediatric ICU, 
1.73 [95% CI, 1.27 to 2.35] among neonates vs. 
1.17 [95% CI, 1.04 to 1.31] among older chil-
dren; P = 0.03 for the interaction). In addition, 
the effect of late parenteral nutrition on primary 
outcomes was unaltered after adjustment for the 
amount of enteral nutrition provided (Table S7 
in the Supplementary Appendix).
Secondary Outcomes
Mortality was similar in the two groups at all 
prespecified time points (Table 2 and Fig. 3). 
The percentage of patients with an episode of 
hypoglycemia (glucose level <40 mg per decili-
ter) was higher in the group receiving late par-
enteral nutrition than in the group receiving 
early parenteral nutrition (Table 2). Adjustment 
for hypoglycemia did not alter the effect size of 
late parenteral nutrition on the primary outcomes 
(odds ratio for new infection, 0.45 [95% CI, 0.32 
to 0.62] and adjusted hazard ratio for the likeli-
hood of an earlier live discharge from the pedi-
atric ICU, 1.26 [95% CI, 1.13 to 1.41]) (Table S7 
in the Supplementary Appendix). Rates of read-
mission to the pediatric ICU within 48 hours 
after discharge and of the occurrence of serious 
adverse events were similar in the two study 
groups (Table 2).
The duration of mechanical ventilatory sup-
port was shorter and the likelihood of being 
weaned alive earlier from mechanical ventilation 
was higher among patients receiving late paren-
teral nutrition than among those receiving early 
parenteral nutrition (Table 2, and Table S5 in the 
Supplementary Appendix), whereas there was no 
significant between-group difference in the du-
ration of hemodynamic support. After adjust-
ment for prespecified risk factors, late paren-
teral nutrition was also associated with a lower 
need for renal-replacement therapy (Table 2, and 
Table S5 in the Supplementary Appendix). The 
peak plasma total bilirubin levels were higher in 
the late-parenteral-nutrition group than in the 
early-parenteral-nutrition group during the first 
7 days in the pediatric ICU (Table 2) and during 
the duration of the pediatric ICU stay (Table S8 
in the Supplementary Appendix), whereas the 
peak plasma γ-glutamyltransferase and alkaline 
phosphatase levels were higher with early paren-
teral nutrition (Table 2). There were no signifi-
cant between-group differences in the results of 
other liver tests (Table 2). Although there were 
fewer new infections with late parenteral nutri-
tion than with early parenteral nutrition, the 
peak plasma levels of C-reactive protein were 
Figure 1. Screening and Randomization.
The scores on the Screening Tool for Risk on Nutritional Status and Growth 
(STRONGkids) range from 0 to 5, with a score of 0 indicating low risk of 
malnutrition, a score of 1 to 3 indicating medium risk, and a score of 4 to 5 
indicating high risk.17 DNR denotes do not resuscitate, and ICU intensive 
care unit.
1440 Underwent randomization
7519 Children (newborn to 17 years of age)
were assessed for eligibility
6079 Were excluded
3592 Were not ill enough to
necessitate nutritional
support
928 Had STRONGkids score <2
408 Were readmissions
178 Were enrolled in another
trial
109 Were transferred from
another neonatal or
pediatric ICU
95 Were premature newborns
73 Had short-bowel syndrome
or other condition requiring
parenteral nutrition
62 Had inborn metabolic
diseases
56 Had ketoacidotic or 
hyperosmolar coma
46 Had DNR code at
admission
32 Had expected death within
12 hr
18 Were >17 years of age
158 Had other reasons
324 Did not have consent
723 Were assigned to early
parenteral nutrition
717 Were assigned to late
parenteral nutrition
723 Were included in the analysis 717 Were included in the analysis
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Characteristic
Early Parenteral 
Nutrition 
(N = 723)
Late Parenteral 
Nutrition 
(N = 717)
Median age (IQR) — yr 1.4 (0.3 to 6.1) 1.5 (0.2 to 7.2)
Age <1 yr — no. (%) 328 (45.4) 325 (45.3)
Male sex — no. (%) 415 (57.4) 415 (57.9)
Median weight (IQR) — kg 10.0 (4.8 to 20.0) 10.3 (4.5 to 21.5)
Median standard deviation score (IQR)† −0.5 (−1.4 to 0.5) −0.4 (−1.4 to 0.5)
Median height (IQR) — cm 80 (58 to 113) 80 (56 to 120)
Median standard deviation score (IQR)† −0.3 (−1.5 to 0.8) −0.3 (−1.4 to 0.8)
Median BMI (IQR) 15 (14–17) 15 (14–17)
Median standard deviation score (IQR)† −0.5 (−1.5 to 0.5) −0.5 (−1.6 to 0.6)
STRONGkids risk level — no. (%)‡
Medium 644 (89.1) 644 (89.8)
High  79 (10.9)  73 (10.2)
Median PELOD score, first 24 hr in pediatric ICU (IQR)§ 21 (11 to 31) 21 (11 to 31)
Emergency admission — no. (%) 383 (53.0) 400 (55.8)
Diagnostic group — no. (%)
Surgical
Abdominal 53 (7.3) 60 (8.4)
Burns  5 (0.7)  5 (0.7)
Cardiac 279 (38.6) 268 (37.3)
Neurosurgery–traumatic brain injury 63 (8.7) 53 (7.3)
Thoracic 34 (4.7) 27 (3.8)
Transplantation  7 (1.0) 17 (2.4)
Orthopedic surgery–trauma 28 (3.9) 26 (3.6)
Other 21 (2.9) 27 (3.8)
Medical
Cardiac 30 (4.1) 31 (4.3)
Gastrointestinal–hepatic  2 (0.3)  4 (0.6)
Oncologic–hematologic  8 (1.1)  7 (1.0)
Neurologic 51 (7.1) 52 (7.3)
Renal  1 (0.1)  1 (0.1)
Respiratory  99 (13.7)  96 (13.4)
Other 42 (5.8) 43 (6.0)
Condition on admission — no. (%)
Mechanical ventilation required 639 (88.4) 622 (86.8)
ECMO or other assist device required 19 (2.6) 25 (3.5)
Infection 287 (39.7) 271 (37.8)
*  There were no significant differences in characteristics between treatment groups at baseline. BMI denotes body-mass 
index (the weight in kilograms divided by the square of the height in meters), ECMO extracorporeal membrane oxygen-
ation, and ICU intensive care unit.
†  Age- and gender-specific standard deviation scores were calculated with the use of reference data from the World Health 
Organization.18
‡  Scores on the Screening Tool for Risk on Nutritional Status and Growth (STRONGkids) range from 0 to 5, with a score of 
0 indicating a low risk of malnutrition, a score of 1 to 3 indicating medium risk, and a score of 4 to 5 indicating high risk.
§  Pediatric Logistic Organ Dysfunction (PELOD) scores range from 0 to 71, with higher scores indicating more severe illness.
Table 1. Baseline Characteristics.*
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Figure 2. Daily Caloric and Macronutrient Intake.
The daily amount of energy (kilocalories per day) and substrate (grams per day) provided by the enteral route, the parenteral route,  
or both (total) are shown for participants’ first 16 days in the pediatric intensive care unit (ICU). I bars indicate the standard error.  
PN denotes parenteral nutrition.
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higher with late parenteral nutrition during the 
first 7 days in the pediatric ICU (Table 2).
The mean duration of stay in the index hos-
pital was 4.1 days shorter (95% CI, 1.4 to 6.6), 
and the likelihood of an earlier discharge alive 
from the hospital was higher (adjusted hazard 
ratio, 1.19; 95% CI, 1.07 to 1.33) in the late-
parenteral-nutrition group than in the early-
parenteral-nutrition group (Table 2 and Fig. 3, 
and Table S5 and Fig. S3 in the Supplementary 
Appendix). This effect of late parenteral nutrition 
remained significant when any eventual addi-
tional stay in a transfer hospital was taken into 
account (Table 2 and Fig. 3, and Table S5 and 
Fig. S3 in the Supplementary Appendix). Adjust-
ments for hypoglycemia or for the amount of 
enterally administered nutrition did not alter the 
effect of late parenteral nutrition on any of the 
secondary outcomes (Table S7 in the Supplemen-
tary Appendix).
Discussion
The results of our trial showed that withholding 
parenteral nutrition for 1 week in the pediatric 
ICU was clinically superior to providing early 
parenteral nutrition; late parenteral nutrition 
resulted in fewer new infections, a shorter dura-
tion of dependency on intensive care, and a 
shorter hospital stay. The clinical superiority of 
late parenteral nutrition was shown irrespective 
of diagnosis, severity of illness, risk of malnutri-
tion, or age of the child. The observation that 
critically ill children at the highest risk of mal-
nutrition benefited the most from the withhold-
ing of early parenteral nutrition was unexpected. 
However, this finding was reinforced by the ap-
parently greater benefit of this strategy for criti-
cally ill term neonates than for older children. 
Indeed, immediate initiation of nutrition is cur-
rently advised for neonates because they are con-
sidered to have lower metabolic reserves.7
The benefits of late parenteral nutrition were 
evident irrespective of the variability in nutri-
tional care and blood-glucose management across 
participating centers. Late parenteral nutrition 
resulted in more instances of hypoglycemia than 
were seen with early parenteral nutrition, but 
this higher rate did not affect the overall effect 
of the intervention on the outcome. In addition, 
in earlier studies, such brief episodes of hypogly-
cemia in critically ill children or in premature or O
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mature newborns were not shown to have a 
negative effect on long-term neurocognitive out-
comes.19-21
The finding that the rate of new infections 
was substantially lower with late parenteral 
nutrition than with early parenteral nutrition 
but that the rate of inflammation (as indicated 
by elevated plasma levels of C-reactive protein) 
was higher illustrates the limitation of surrogate 
end points in clinical trials.22-26 As was seen in a 
previous study involving adults, plasma levels 
of γ-glutamyltransferase and alkaline phospha-
tase were lower in children who received late 
parenteral nutrition than in those who received 
early parenteral nutrition, a finding that was 
suggestive of less cholestasis in children in the 
late-parenteral-nutrition group.13,27,28 However, 
late parenteral nutrition resulted in higher plasma 
bilirubin levels than did early parenteral nutri-
tion in these critically ill children, as it has in 
Figure 3. Kaplan–Meier Plots for the Time to Discharge and for Survival Up to 90 Days.
Panels A, B, and C show the cumulative proportions of patients discharged from the pediatric ICU, the index hospital, and all hospitals 
(index and transfer hospitals), respectively. Data for surviving patients were censored at 90 days, whereas data for nonsurvivors were 
censored at the time of death. For the sake of clarity, only the first 30 days are shown. Panel D shows the survival rate up to 90 days.  
P values were adjusted for diagnostic group, age group, severity of illness, risk of malnutrition, and treatment center.
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adult patients, which provides further support for 
the concept that increases in plasma bilirubin 
levels in response to critical illness may be 
partially adaptive.29
The underlying mechanisms of the clinical 
benefits observed when there is a substantial 
macronutrient deficit early in critical illness in 
children remain speculative. Preservation of au-
tophagy may play a role, given its importance for 
innate immunity and for quality control in cells 
with a long half-life, such as myofibers.30-32
A limitation of this study is that the patients, 
their parents, and the staff providing intensive 
care were aware of the treatment assignments. 
However, outcome assessors and caregivers on 
the pediatric wards were unaware of the treat-
ment assignments. The strength of the study is 
its external validity, given the multicenter study 
design. In conclusion, in critically ill children, 
withholding parenteral nutrition for 1 week while 
administering micronutrients intravenously was 
clinically superior to providing early parenteral 
nutrition to supplement insufficient enteral nu-
trition.
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